Efficacy and Safety of IVM/ALB Co-administration

NCT03527732 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1673

Enrollment

OTHER

Sponsor class

Conditions

Trichuriasis

Interventions

DRUG: Albendazole
DRUG: Albendazole and Ivermectin

Sponsor

Jennifer Keiser

Collaborators

[object Object]
[object Object]
[object Object]